EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
-7.75%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$114M
AUM Growth
+$114M
(+6.6%)
Cap. Flow
+$20.3M
Cap. Flow
% of AUM
17.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
iShares MSCI India ETF
INDA
|
$24.5M |
Top Sells
| 1 |
First Financial Bancorp
FFBC
|
$4.21M |
Sector Composition
| 1 | Healthcare | 58.55% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI India ETF
INDA
$9.17B
| $47.2M | 41.45% |
1,200,144
+623,000
| +108% | +$24.5M |
|
|
ME
2
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $23.4M | 20.49% |
10,243,122
| – | – |
|
3
PMV Pharmaceuticals
PMVP
$74.2M
| $11.1M | 9.78% |
2,336,909
| – | – |
|
4
RAPT Therapeutics
RAPT
$188M
| $7.94M | 6.97% |
432,900
| – | – |
|
5
Foghorn Therapeutics
FHTX
$286M
| $7.82M | 6.86% |
1,261,261
| – | – |
|
6
Alector
ALEC
$238M
| $6.07M | 5.33% |
980,894
| – | – |
|
7
Oric Pharmaceuticals
ORIC
$994M
| $4.26M | 3.74% |
747,550
| – | – |
|
|
NGM
8
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.05M | 2.67% |
746,674
| – | – |
|
9
Tenaya Therapeutics
TNYA
$184M
| $2.61M | 2.29% |
915,705
| – | – |
|
10
Surrozen
SRZN
$104M
| $483K | 0.42% |
802,963
| – | – |
|
|
11
First Financial Bancorp
FFBC
$2.51B
| – | – |
-173,576
| Closed | -$4.21M |
|